Egrifta (Tesamorelin Acetate) Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Egrifta (Tesamorelin Acetate) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on egrifta (tesamorelin acetate) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for egrifta (tesamorelin acetate) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The egrifta (tesamorelin acetate) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Clinical Indication: Human Immunodeficiency Virus (HIV)-Associated Lipodystrophy; Growth Hormone Deficiency; Abdominal Obesity; Metabolic Syndrome

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels

3) By End-Users: Hospitals; Specialized Clinics; Home Care

Companies Mentioned: Theratechnologies Inc.

Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Egrifta (Tesamorelin Acetate) Market Characteristics
3. Egrifta (Tesamorelin Acetate) Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route Of Administration (ROA)
3.3. Mechanism Of Action (MOA)
3.4. Safety And Efficacy
4. Egrifta (Tesamorelin Acetate) Market Trends And Strategies
5. Egrifta (Tesamorelin Acetate) Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
6. Global Egrifta (Tesamorelin Acetate) Growth Analysis And Strategic Analysis Framework
6.1. Global Egrifta (Tesamorelin Acetate) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis Of End Use Industries
6.3. Global Egrifta (Tesamorelin Acetate) Market Growth Rate Analysis
6.4. Global Egrifta (Tesamorelin Acetate) Historic Market Size and Growth, 2019 - 2024, Value ($ Million)
6.5. Global Egrifta (Tesamorelin Acetate) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)
6.6. Global Egrifta (Tesamorelin Acetate) Total Addressable Market (TAM)
7. Global Egrifta (Tesamorelin Acetate) Pricing Analysis & Forecasts
8. Egrifta (Tesamorelin Acetate) Market Segmentation
8.1. Global Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
Human Immunodeficiency Virus (HIV)-Associated Lipodystrophy
Growth Hormone Deficiency
Abdominal Obesity
Metabolic Syndrome
8.2. Global Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
8.3. Global Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
Hospitals
Specialized Clinics
Home Care
9. Global Egrifta (Tesamorelin Acetate) Epidemiology Of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence And Prevalence of Clinical Indications
10. Egrifta (Tesamorelin Acetate) Market Regional And Country Analysis
10.1. Global Egrifta (Tesamorelin Acetate) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
10.2. Global Egrifta (Tesamorelin Acetate) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11. Asia-Pacific Egrifta (Tesamorelin Acetate) Market
11.1. Asia-Pacific Egrifta (Tesamorelin Acetate) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.3. Asia-Pacific Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
11.4. Asia-Pacific Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
12. China Egrifta (Tesamorelin Acetate) Market
12.1. China Egrifta (Tesamorelin Acetate) Market Overview
12.2. China Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.3. China Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
12.4. China Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million
13. India Egrifta (Tesamorelin Acetate) Market
13.1. India Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.2. India Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
13.3. India Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14. Japan Egrifta (Tesamorelin Acetate) Market
14.1. Japan Egrifta (Tesamorelin Acetate) Market Overview
14.2. Japan Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.3. Japan Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
14.4. Japan Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15. Australia Egrifta (Tesamorelin Acetate) Market
15.1. Australia Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.2. Australia Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
15.3. Australia Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16. South Korea Egrifta (Tesamorelin Acetate) Market
16.1. South Korea Egrifta (Tesamorelin Acetate) Market Overview
16.2. South Korea Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.3. South Korea Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
16.4. South Korea Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17. Western Europe Egrifta (Tesamorelin Acetate) Market
17.1. Western Europe Egrifta (Tesamorelin Acetate) Market Overview
17.2. Western Europe Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.3. Western Europe Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
17.4. Western Europe Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18. UK Egrifta (Tesamorelin Acetate) Market
18.1. UK Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.2. UK Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
18.3. UK Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19. Germany Egrifta (Tesamorelin Acetate) Market
19.1. Germany Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.2. Germany Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
19.3. Germany Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20. France Egrifta (Tesamorelin Acetate) Market
20.1. France Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.2. France Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
20.3. France Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21. Eastern Europe Egrifta (Tesamorelin Acetate) Market
21.1. Eastern Europe Egrifta (Tesamorelin Acetate) Market Overview
21.2. Eastern Europe Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.3. Eastern Europe Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
21.4. Eastern Europe Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22. North America Egrifta (Tesamorelin Acetate) Market
22.1. North America Egrifta (Tesamorelin Acetate) Market Overview
22.2. North America Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.3. North America Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
22.4. North America Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23. USA Egrifta (Tesamorelin Acetate) Market
23.1. USA Egrifta (Tesamorelin Acetate) Market Overview
23.2. USA Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.3. USA Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
23.4. USA Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24. Canada Egrifta (Tesamorelin Acetate) Market
24.1. Canada Egrifta (Tesamorelin Acetate) Market Overview
24.2. Canada Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.3. Canada Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
24.4. Canada Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25. South America Egrifta (Tesamorelin Acetate) Market
25.1. South America Egrifta (Tesamorelin Acetate) Market Overview
25.2. South America Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.3. South America Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
25.4. South America Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26. Middle East Egrifta (Tesamorelin Acetate) Market
26.1. Middle East Egrifta (Tesamorelin Acetate) Market Overview
26.2. Middle East Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.3. Middle East Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
26.4. Middle East Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27. Africa Egrifta (Tesamorelin Acetate) Market
27.1. Africa Egrifta (Tesamorelin Acetate) Market Overview
27.2. Africa Egrifta (Tesamorelin Acetate) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.3. Africa Egrifta (Tesamorelin Acetate) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
27.4. Africa Egrifta (Tesamorelin Acetate) Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
28. Egrifta (Tesamorelin Acetate) Market Competitive Landscape And Company Profiles
28.1. Egrifta (Tesamorelin Acetate) Market Competitive Landscape
28.2. Egrifta (Tesamorelin Acetate) Market Company Profiles
28.2.1. Theratechnologies Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Egrifta (Tesamorelin Acetate) Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Egrifta (Tesamorelin Acetate) Market Competitive Benchmarking And Dashboard
31. Key Mergers And Acquisitions In The Egrifta (Tesamorelin Acetate) Market
32. Recent Developments In The Egrifta (Tesamorelin Acetate) Market
33. Egrifta (Tesamorelin Acetate) Market High Potential Countries, Segments and Strategies
33.1 Egrifta (Tesamorelin Acetate) Market In 2029 - Countries Offering Most New Opportunities
33.2 Egrifta (Tesamorelin Acetate) Market In 2029 - Segments Offering Most New Opportunities
33.3 Egrifta (Tesamorelin Acetate) Market In 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic And Forecast Inflation Rates
34.4. Research Inquiries
34.5. The Business Research Company
34.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings